Page last updated: 2024-12-07

9-hydroxyellipticine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

9-Hydroxyellipticine is a synthetic derivative of ellipticine, a natural alkaloid found in the plant Ochrosia grandiflora. It exhibits potent cytotoxic activity against various cancer cell lines, particularly those resistant to conventional chemotherapies. Its mechanism of action involves intercalation into DNA, inhibiting DNA replication and transcription. 9-Hydroxyellipticine is studied for its potential as a therapeutic agent for treating cancers, particularly those with resistance to existing treatments. Its unique structure and pharmacological profile make it a promising candidate for further development as an anticancer drug.'

9-hydroxyellipticine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

9-hydroxyellipticine : A organic heterotetracyclic compound that is ellipticine in which the hydrogen at position 9 has been replaced by a hydroxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID91643
CHEMBL ID26559
CHEBI ID88297
SCHEMBL ID564035
MeSH IDM0051523

Synonyms (47)

Synonym
5,11-dimethyl-6h-pyrido(4,3-b)carbazol-9-ol
6h-pyrido(4,3-b)carbazol-9-ol, 5,11-dimethyl-
nsc 210717
nsc 237070
hydroxy-9 ellipticine [french]
einecs 257-000-0
igig 929
hydroxyellipticine
5,11-dimethyl-6h-pyrido[4,3-b]carbazol-9-ol
ellipticine,9-hydroxy
51131-85-2
nsc-237070
9-hydroxyellipticin
9-hydroxyellipticine
ellipticine, 9-hydroxy-
nsc237070
NCI60_001766
SMP2_000298
nsc-210717
chebi:88297 ,
CHEMBL26559 ,
bdbm50004227
5,11-dimethyl-6h-pyrido[3,4-h]carbazol-9-ol
hydroxy-9 ellipticine
unii-9g4a3et6xg
9g4a3et6xg ,
SCHEMBL564035
9-hydroxy-ellipticine
QZTWUDDGLIDXSE-UHFFFAOYSA-N
9-hydroxy-5,11-dimethyl-6h-pyrido[4,3-b]carbazole
9-hydroxyellipticin free base
9-hydroxy-5,11-dimethyl-6h-pyrido(4,3-b)carbazole
hydroxyellipticine, 9-
9he
9-oh-e
DTXSID30199153
6h-pyrido[4,3-b]carbazol-9-ol, 5,11-dimethyl-
AKOS027324603
5,11-dimethyl-6h-pyrido[4,3-b]carbazol-9-ol monohydrochloride
icig-929
Q27160170
BCP23684
51131-85-2 (free base)
igig929
EN300-18531135
EX-A5668
PD069757
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
organonitrogen heterocyclic compoundAny organonitrogen compound containing a cyclic component with nitrogen and at least one other element as ring member atoms.
organic heterotetracyclic compound
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Mast/stem cell growth factor receptor KitHomo sapiens (human)IC50 (µMol)0.20500.00070.470810.0000AID255004; AID255976; AID255987; AID256551
Platelet-derived growth factor receptor alphaHomo sapiens (human)IC50 (µMol)0.60000.00010.491210.0000AID254810
Fibroblast growth factor receptor 3Homo sapiens (human)IC50 (µMol)0.40000.00040.28638.6200AID254753
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (124)

Processvia Protein(s)Taxonomy
ovarian follicle developmentMast/stem cell growth factor receptor KitHomo sapiens (human)
myeloid progenitor cell differentiationMast/stem cell growth factor receptor KitHomo sapiens (human)
lymphoid progenitor cell differentiationMast/stem cell growth factor receptor KitHomo sapiens (human)
immature B cell differentiationMast/stem cell growth factor receptor KitHomo sapiens (human)
mast cell chemotaxisMast/stem cell growth factor receptor KitHomo sapiens (human)
positive regulation of dendritic cell cytokine productionMast/stem cell growth factor receptor KitHomo sapiens (human)
glycosphingolipid metabolic processMast/stem cell growth factor receptor KitHomo sapiens (human)
inflammatory responseMast/stem cell growth factor receptor KitHomo sapiens (human)
signal transductionMast/stem cell growth factor receptor KitHomo sapiens (human)
spermatogenesisMast/stem cell growth factor receptor KitHomo sapiens (human)
spermatid developmentMast/stem cell growth factor receptor KitHomo sapiens (human)
germ cell migrationMast/stem cell growth factor receptor KitHomo sapiens (human)
regulation of cell shapeMast/stem cell growth factor receptor KitHomo sapiens (human)
visual learningMast/stem cell growth factor receptor KitHomo sapiens (human)
male gonad developmentMast/stem cell growth factor receptor KitHomo sapiens (human)
positive regulation of phospholipase C activityMast/stem cell growth factor receptor KitHomo sapiens (human)
cytokine-mediated signaling pathwayMast/stem cell growth factor receptor KitHomo sapiens (human)
stem cell population maintenanceMast/stem cell growth factor receptor KitHomo sapiens (human)
lamellipodium assemblyMast/stem cell growth factor receptor KitHomo sapiens (human)
actin cytoskeleton organizationMast/stem cell growth factor receptor KitHomo sapiens (human)
hemopoiesisMast/stem cell growth factor receptor KitHomo sapiens (human)
T cell differentiationMast/stem cell growth factor receptor KitHomo sapiens (human)
erythrocyte differentiationMast/stem cell growth factor receptor KitHomo sapiens (human)
melanocyte differentiationMast/stem cell growth factor receptor KitHomo sapiens (human)
positive regulation of pseudopodium assemblyMast/stem cell growth factor receptor KitHomo sapiens (human)
positive regulation of mast cell cytokine productionMast/stem cell growth factor receptor KitHomo sapiens (human)
somatic stem cell population maintenanceMast/stem cell growth factor receptor KitHomo sapiens (human)
embryonic hemopoiesisMast/stem cell growth factor receptor KitHomo sapiens (human)
ectopic germ cell programmed cell deathMast/stem cell growth factor receptor KitHomo sapiens (human)
intracellular signal transductionMast/stem cell growth factor receptor KitHomo sapiens (human)
hematopoietic stem cell migrationMast/stem cell growth factor receptor KitHomo sapiens (human)
megakaryocyte developmentMast/stem cell growth factor receptor KitHomo sapiens (human)
Fc receptor signaling pathwayMast/stem cell growth factor receptor KitHomo sapiens (human)
Kit signaling pathwayMast/stem cell growth factor receptor KitHomo sapiens (human)
erythropoietin-mediated signaling pathwayMast/stem cell growth factor receptor KitHomo sapiens (human)
regulation of cell population proliferationMast/stem cell growth factor receptor KitHomo sapiens (human)
positive regulation of tyrosine phosphorylation of STAT proteinMast/stem cell growth factor receptor KitHomo sapiens (human)
negative regulation of programmed cell deathMast/stem cell growth factor receptor KitHomo sapiens (human)
mast cell degranulationMast/stem cell growth factor receptor KitHomo sapiens (human)
positive regulation of MAPK cascadeMast/stem cell growth factor receptor KitHomo sapiens (human)
pigmentationMast/stem cell growth factor receptor KitHomo sapiens (human)
tongue developmentMast/stem cell growth factor receptor KitHomo sapiens (human)
positive regulation of Notch signaling pathwayMast/stem cell growth factor receptor KitHomo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATMast/stem cell growth factor receptor KitHomo sapiens (human)
response to cadmium ionMast/stem cell growth factor receptor KitHomo sapiens (human)
protein autophosphorylationMast/stem cell growth factor receptor KitHomo sapiens (human)
positive regulation of long-term neuronal synaptic plasticityMast/stem cell growth factor receptor KitHomo sapiens (human)
digestive tract developmentMast/stem cell growth factor receptor KitHomo sapiens (human)
stem cell differentiationMast/stem cell growth factor receptor KitHomo sapiens (human)
epithelial cell proliferationMast/stem cell growth factor receptor KitHomo sapiens (human)
detection of mechanical stimulus involved in sensory perception of soundMast/stem cell growth factor receptor KitHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityMast/stem cell growth factor receptor KitHomo sapiens (human)
negative regulation of developmental processMast/stem cell growth factor receptor KitHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionMast/stem cell growth factor receptor KitHomo sapiens (human)
cell chemotaxisMast/stem cell growth factor receptor KitHomo sapiens (human)
mast cell differentiationMast/stem cell growth factor receptor KitHomo sapiens (human)
mast cell proliferationMast/stem cell growth factor receptor KitHomo sapiens (human)
positive regulation of mast cell proliferationMast/stem cell growth factor receptor KitHomo sapiens (human)
melanocyte migrationMast/stem cell growth factor receptor KitHomo sapiens (human)
melanocyte adhesionMast/stem cell growth factor receptor KitHomo sapiens (human)
positive regulation of pyloric antrum smooth muscle contractionMast/stem cell growth factor receptor KitHomo sapiens (human)
regulation of bile acid metabolic processMast/stem cell growth factor receptor KitHomo sapiens (human)
positive regulation of colon smooth muscle contractionMast/stem cell growth factor receptor KitHomo sapiens (human)
positive regulation of small intestine smooth muscle contractionMast/stem cell growth factor receptor KitHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell differentiationMast/stem cell growth factor receptor KitHomo sapiens (human)
negative regulation of reproductive processMast/stem cell growth factor receptor KitHomo sapiens (human)
positive regulation of cell migrationMast/stem cell growth factor receptor KitHomo sapiens (human)
positive regulation of MAP kinase activityMast/stem cell growth factor receptor KitHomo sapiens (human)
multicellular organism developmentMast/stem cell growth factor receptor KitHomo sapiens (human)
B cell differentiationMast/stem cell growth factor receptor KitHomo sapiens (human)
hematopoietic progenitor cell differentiationMast/stem cell growth factor receptor KitHomo sapiens (human)
cellular response to reactive oxygen speciesPlatelet-derived growth factor receptor alphaHomo sapiens (human)
luteinizationPlatelet-derived growth factor receptor alphaHomo sapiens (human)
in utero embryonic developmentPlatelet-derived growth factor receptor alphaHomo sapiens (human)
cell activationPlatelet-derived growth factor receptor alphaHomo sapiens (human)
hematopoietic progenitor cell differentiationPlatelet-derived growth factor receptor alphaHomo sapiens (human)
estrogen metabolic processPlatelet-derived growth factor receptor alphaHomo sapiens (human)
positive regulation of cell population proliferationPlatelet-derived growth factor receptor alphaHomo sapiens (human)
negative regulation of platelet activationPlatelet-derived growth factor receptor alphaHomo sapiens (human)
positive regulation of phospholipase C activityPlatelet-derived growth factor receptor alphaHomo sapiens (human)
peptidyl-tyrosine phosphorylationPlatelet-derived growth factor receptor alphaHomo sapiens (human)
signal transduction involved in regulation of gene expressionPlatelet-derived growth factor receptor alphaHomo sapiens (human)
extracellular matrix organizationPlatelet-derived growth factor receptor alphaHomo sapiens (human)
lung developmentPlatelet-derived growth factor receptor alphaHomo sapiens (human)
adrenal gland developmentPlatelet-derived growth factor receptor alphaHomo sapiens (human)
positive regulation of cell migrationPlatelet-derived growth factor receptor alphaHomo sapiens (human)
male genitalia developmentPlatelet-derived growth factor receptor alphaHomo sapiens (human)
regulation of actin cytoskeleton organizationPlatelet-derived growth factor receptor alphaHomo sapiens (human)
Leydig cell differentiationPlatelet-derived growth factor receptor alphaHomo sapiens (human)
platelet-derived growth factor receptor-alpha signaling pathwayPlatelet-derived growth factor receptor alphaHomo sapiens (human)
positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathwayPlatelet-derived growth factor receptor alphaHomo sapiens (human)
wound healingPlatelet-derived growth factor receptor alphaHomo sapiens (human)
odontogenesis of dentin-containing toothPlatelet-derived growth factor receptor alphaHomo sapiens (human)
protein autophosphorylationPlatelet-derived growth factor receptor alphaHomo sapiens (human)
platelet-derived growth factor receptor signaling pathwayPlatelet-derived growth factor receptor alphaHomo sapiens (human)
positive regulation of fibroblast proliferationPlatelet-derived growth factor receptor alphaHomo sapiens (human)
embryonic digestive tract morphogenesisPlatelet-derived growth factor receptor alphaHomo sapiens (human)
embryonic cranial skeleton morphogenesisPlatelet-derived growth factor receptor alphaHomo sapiens (human)
embryonic skeletal system morphogenesisPlatelet-derived growth factor receptor alphaHomo sapiens (human)
positive regulation of calcium-mediated signalingPlatelet-derived growth factor receptor alphaHomo sapiens (human)
white fat cell differentiationPlatelet-derived growth factor receptor alphaHomo sapiens (human)
positive regulation of chemotaxisPlatelet-derived growth factor receptor alphaHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionPlatelet-derived growth factor receptor alphaHomo sapiens (human)
cardiac myofibril assemblyPlatelet-derived growth factor receptor alphaHomo sapiens (human)
roof of mouth developmentPlatelet-derived growth factor receptor alphaHomo sapiens (human)
face morphogenesisPlatelet-derived growth factor receptor alphaHomo sapiens (human)
cell chemotaxisPlatelet-derived growth factor receptor alphaHomo sapiens (human)
retina vasculature development in camera-type eyePlatelet-derived growth factor receptor alphaHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadePlatelet-derived growth factor receptor alphaHomo sapiens (human)
platelet aggregationPlatelet-derived growth factor receptor alphaHomo sapiens (human)
cellular response to amino acid stimulusPlatelet-derived growth factor receptor alphaHomo sapiens (human)
metanephric glomerular capillary formationPlatelet-derived growth factor receptor alphaHomo sapiens (human)
regulation of mesenchymal stem cell differentiationPlatelet-derived growth factor receptor alphaHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayPlatelet-derived growth factor receptor alphaHomo sapiens (human)
positive regulation of kinase activityPlatelet-derived growth factor receptor alphaHomo sapiens (human)
multicellular organism developmentPlatelet-derived growth factor receptor alphaHomo sapiens (human)
positive regulation of cell population proliferationFibroblast growth factor receptor 3Homo sapiens (human)
fibroblast growth factor receptor signaling pathwayFibroblast growth factor receptor 3Homo sapiens (human)
MAPK cascadeFibroblast growth factor receptor 3Homo sapiens (human)
skeletal system developmentFibroblast growth factor receptor 3Homo sapiens (human)
endochondral ossificationFibroblast growth factor receptor 3Homo sapiens (human)
chondrocyte differentiationFibroblast growth factor receptor 3Homo sapiens (human)
endochondral bone growthFibroblast growth factor receptor 3Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STATFibroblast growth factor receptor 3Homo sapiens (human)
cell-cell signalingFibroblast growth factor receptor 3Homo sapiens (human)
positive regulation of cell population proliferationFibroblast growth factor receptor 3Homo sapiens (human)
fibroblast growth factor receptor signaling pathwayFibroblast growth factor receptor 3Homo sapiens (human)
positive regulation of phospholipase activityFibroblast growth factor receptor 3Homo sapiens (human)
bone mineralizationFibroblast growth factor receptor 3Homo sapiens (human)
chondrocyte proliferationFibroblast growth factor receptor 3Homo sapiens (human)
positive regulation of tyrosine phosphorylation of STAT proteinFibroblast growth factor receptor 3Homo sapiens (human)
positive regulation of MAPK cascadeFibroblast growth factor receptor 3Homo sapiens (human)
negative regulation of developmental growthFibroblast growth factor receptor 3Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionFibroblast growth factor receptor 3Homo sapiens (human)
bone morphogenesisFibroblast growth factor receptor 3Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeFibroblast growth factor receptor 3Homo sapiens (human)
bone maturationFibroblast growth factor receptor 3Homo sapiens (human)
fibroblast growth factor receptor apoptotic signaling pathwayFibroblast growth factor receptor 3Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayFibroblast growth factor receptor 3Homo sapiens (human)
multicellular organism developmentFibroblast growth factor receptor 3Homo sapiens (human)
positive regulation of kinase activityFibroblast growth factor receptor 3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (21)

Processvia Protein(s)Taxonomy
protease bindingMast/stem cell growth factor receptor KitHomo sapiens (human)
protein tyrosine kinase activityMast/stem cell growth factor receptor KitHomo sapiens (human)
transmembrane receptor protein tyrosine kinase activityMast/stem cell growth factor receptor KitHomo sapiens (human)
stem cell factor receptor activityMast/stem cell growth factor receptor KitHomo sapiens (human)
protein bindingMast/stem cell growth factor receptor KitHomo sapiens (human)
ATP bindingMast/stem cell growth factor receptor KitHomo sapiens (human)
cytokine bindingMast/stem cell growth factor receptor KitHomo sapiens (human)
SH2 domain bindingMast/stem cell growth factor receptor KitHomo sapiens (human)
protein homodimerization activityMast/stem cell growth factor receptor KitHomo sapiens (human)
metal ion bindingMast/stem cell growth factor receptor KitHomo sapiens (human)
growth factor bindingMast/stem cell growth factor receptor KitHomo sapiens (human)
protein kinase activityPlatelet-derived growth factor receptor alphaHomo sapiens (human)
transmembrane receptor protein tyrosine kinase activityPlatelet-derived growth factor receptor alphaHomo sapiens (human)
platelet-derived growth factor alpha-receptor activityPlatelet-derived growth factor receptor alphaHomo sapiens (human)
vascular endothelial growth factor receptor activityPlatelet-derived growth factor receptor alphaHomo sapiens (human)
platelet-derived growth factor receptor bindingPlatelet-derived growth factor receptor alphaHomo sapiens (human)
protein bindingPlatelet-derived growth factor receptor alphaHomo sapiens (human)
ATP bindingPlatelet-derived growth factor receptor alphaHomo sapiens (human)
vascular endothelial growth factor bindingPlatelet-derived growth factor receptor alphaHomo sapiens (human)
protein homodimerization activityPlatelet-derived growth factor receptor alphaHomo sapiens (human)
protein-containing complex bindingPlatelet-derived growth factor receptor alphaHomo sapiens (human)
platelet-derived growth factor bindingPlatelet-derived growth factor receptor alphaHomo sapiens (human)
protein tyrosine kinase activityFibroblast growth factor receptor 3Homo sapiens (human)
fibroblast growth factor receptor activityFibroblast growth factor receptor 3Homo sapiens (human)
protein bindingFibroblast growth factor receptor 3Homo sapiens (human)
ATP bindingFibroblast growth factor receptor 3Homo sapiens (human)
fibroblast growth factor bindingFibroblast growth factor receptor 3Homo sapiens (human)
identical protein bindingFibroblast growth factor receptor 3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (23)

Processvia Protein(s)Taxonomy
fibrillar centerMast/stem cell growth factor receptor KitHomo sapiens (human)
acrosomal vesicleMast/stem cell growth factor receptor KitHomo sapiens (human)
extracellular spaceMast/stem cell growth factor receptor KitHomo sapiens (human)
plasma membraneMast/stem cell growth factor receptor KitHomo sapiens (human)
cell-cell junctionMast/stem cell growth factor receptor KitHomo sapiens (human)
external side of plasma membraneMast/stem cell growth factor receptor KitHomo sapiens (human)
cytoplasmic side of plasma membraneMast/stem cell growth factor receptor KitHomo sapiens (human)
plasma membraneMast/stem cell growth factor receptor KitHomo sapiens (human)
receptor complexMast/stem cell growth factor receptor KitHomo sapiens (human)
nucleusPlatelet-derived growth factor receptor alphaHomo sapiens (human)
nucleoplasmPlatelet-derived growth factor receptor alphaHomo sapiens (human)
cytoplasmPlatelet-derived growth factor receptor alphaHomo sapiens (human)
endoplasmic reticulum membranePlatelet-derived growth factor receptor alphaHomo sapiens (human)
Golgi apparatusPlatelet-derived growth factor receptor alphaHomo sapiens (human)
plasma membranePlatelet-derived growth factor receptor alphaHomo sapiens (human)
microvillusPlatelet-derived growth factor receptor alphaHomo sapiens (human)
ciliumPlatelet-derived growth factor receptor alphaHomo sapiens (human)
external side of plasma membranePlatelet-derived growth factor receptor alphaHomo sapiens (human)
membranePlatelet-derived growth factor receptor alphaHomo sapiens (human)
cell junctionPlatelet-derived growth factor receptor alphaHomo sapiens (human)
protein-containing complexPlatelet-derived growth factor receptor alphaHomo sapiens (human)
receptor complexPlatelet-derived growth factor receptor alphaHomo sapiens (human)
plasma membranePlatelet-derived growth factor receptor alphaHomo sapiens (human)
focal adhesionFibroblast growth factor receptor 3Homo sapiens (human)
extracellular regionFibroblast growth factor receptor 3Homo sapiens (human)
endoplasmic reticulumFibroblast growth factor receptor 3Homo sapiens (human)
Golgi apparatusFibroblast growth factor receptor 3Homo sapiens (human)
plasma membraneFibroblast growth factor receptor 3Homo sapiens (human)
cell surfaceFibroblast growth factor receptor 3Homo sapiens (human)
transport vesicleFibroblast growth factor receptor 3Homo sapiens (human)
receptor complexFibroblast growth factor receptor 3Homo sapiens (human)
plasma membraneFibroblast growth factor receptor 3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (61)

Assay IDTitleYearJournalArticle
AID117507The effect on oxygen uptake in the presence of MPO-H2O2 at pH 6.81981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID614174Inhibition of Escherichia coli DdlB assessed as residual activity of the enzyme assessed as orthophosphate formation after 20 mins by malachite green reagent method2011Bioorganic & medicinal chemistry, Sep-01, Volume: 19, Issue:17
Ellipticines and 9-acridinylamines as inhibitors of D-alanine:D-alanine ligase.
AID97903Compound was tested for its cytotoxic activity against murine leukemia L1210 cells in mice after intraperitoneal treatment, expressed as LD0 (highest nonlethal dose).1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID90125Concentration yielding an amount of cellular protein at the end of the incubation that is the same as at the beginning of the incubation in brain tumor sub panel1994Journal of medicinal chemistry, Jul-08, Volume: 37, Issue:14
Anticancer specificity of some ellipticinium salts against human brain tumors in vitro.
AID1339128Binding affinity to salmon sperm DNA assessed as DNA intercalation at 0.04 mole fraction after 5 mins by UV-Vis spectroscopic method2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Determination of binding modes and binding constants for the complexes of 6H-pyrido[4,3-b]carbazole derivatives with DNA.
AID117797The effect on NADH oxidation in the presence of MPO-H2O2 without the compound at pH 8.31981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID117501The effect on NADH oxidation in the presence of MPO-H2O2.1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID255987Inhibitory concentration against IL-3 independent Ba/F3 Kit cell line with SCF (kit-ligand)2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Molecular modeling of wild-type and D816V c-Kit inhibition based on ATP-competitive binding of ellipticine derivatives to tyrosine kinases.
AID130806Antitumor activity against ip implanted syngeneic L1210 leukemia in mouse after ip administration of 60 mg/kg for 5 days expressed as increase in mean life span1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Synthesis and antitumor activity of quaternary ellipticine glycosides, a series of novel and highly active antitumor agents.
AID96644Compound was tested for its antitumor activity against murine leukemia L1210 cells in vitro, expressed as ID501981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID614176Antimicrobial activity against AcrAB-deficient Escherichia coli SM1411 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, Sep-01, Volume: 19, Issue:17
Ellipticines and 9-acridinylamines as inhibitors of D-alanine:D-alanine ligase.
AID1339129Binding affinity to synthetic biotin-labeled 30-mer AT-rich duplex DNA in pH 7.4 EDTA buffer solution in presence of 0.05 M NaCl at 25 degC by QCM sensogram analysis2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Determination of binding modes and binding constants for the complexes of 6H-pyrido[4,3-b]carbazole derivatives with DNA.
AID117792The effect on NADH oxidation in the presence of MPO-H2O2 at pH 7.81981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID117505The effect on oxygen uptake in the presence of MPO-H2O2 at pH 7.81981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID98049The effective dose against L1210 cell growth1985Journal of medicinal chemistry, Jun, Volume: 28, Issue:6
Ellipticine derivatives with an affinity to the estrogen receptor, an approach to develop intercalating drugs with a specific effect on the hormone-dependent breast cancer.
AID117793The effect on NADH oxidation in the presence of MPO-H2O2 at pH 8.31981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID132178Inhibition of sc implanted syngeneic colon 38 carcinoma by ip administration on 1, 3, 5, 7, 9 days measured as inhibition ratio; NT=Not tested1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Synthesis and antitumor activity of quaternary ellipticine glycosides, a series of novel and highly active antitumor agents.
AID117789The effect on NADH oxidation in the presence of MPO-H2O2 at pH 6.01981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID90126Concentration yielding an amount of cellular protein at the end of the incubation that is the same as at the beginning of the incubation in full panel1994Journal of medicinal chemistry, Jul-08, Volume: 37, Issue:14
Anticancer specificity of some ellipticinium salts against human brain tumors in vitro.
AID130787Antitumor activity against i implanted syngeneic L1210 leukemia in mouse after ip administration 5 days expressed as increase in mean life span; NT=Not tested1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Synthesis and antitumor activity of quaternary ellipticine glycosides, a series of novel and highly active antitumor agents.
AID1339130Binding affinity to synthetic biotin-labeled 30-mer GC-rich duplex DNA in pH 7.4 EDTA buffer solution in presence of 0.05 M NaCl at 25 degC by QCM sensogram analysis2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Determination of binding modes and binding constants for the complexes of 6H-pyrido[4,3-b]carbazole derivatives with DNA.
AID130802Antitumor activity against ip implanted P388 leukemia in mouse after ip administration of 30 mg/kg for 5 days expressed as increase in mean life span1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Synthesis and antitumor activity of quaternary ellipticine glycosides, a series of novel and highly active antitumor agents.
AID117512The effect on oxygen uptake in the presence of MPO-H2O2 without the compound at pH 7.81981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID254753Inhibitory activity against Fibroblast growth factor receptor 32005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Molecular modeling of wild-type and D816V c-Kit inhibition based on ATP-competitive binding of ellipticine derivatives to tyrosine kinases.
AID143742Cytotoxicity against N 417 human lung cancer cell line1992Journal of medicinal chemistry, Dec-25, Volume: 35, Issue:26
N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
AID117511The effect on oxygen uptake in the presence of MPO-H2O2 without the compound at pH 7.41981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID231710Ratio between brain tumor full panel [A] and sub panel [B]1994Journal of medicinal chemistry, Jul-08, Volume: 37, Issue:14
Anticancer specificity of some ellipticinium salts against human brain tumors in vitro.
AID1339149Cytotoxicity against mouse Sarcoma 180 cells assessed as reduction in cell viability after 72 hrs by MTT assay2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Determination of binding modes and binding constants for the complexes of 6H-pyrido[4,3-b]carbazole derivatives with DNA.
AID78565Cytotoxicity against H69 human lung cancer cell line1992Journal of medicinal chemistry, Dec-25, Volume: 35, Issue:26
N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
AID117794The effect on NADH oxidation in the presence of MPO-H2O2 without compound at pH 7.41981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID117513The effect on oxygen uptake in the presence of MPO-H2O2 without the compound at pH 8.31981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID256551Inhibitory concentration against c-Kit D816V type expressed in recombinant baculovirus2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Molecular modeling of wild-type and D816V c-Kit inhibition based on ATP-competitive binding of ellipticine derivatives to tyrosine kinases.
AID1339150Cytotoxicity against mouse NIH/3T3 cells assessed as reduction in cell viability after 72 hrs by MTT assay2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Determination of binding modes and binding constants for the complexes of 6H-pyrido[4,3-b]carbazole derivatives with DNA.
AID117509The effect on oxygen uptake in the presence of MPO-H2O2 without the compound at pH 6.01981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID235001TGI correlation coefficient value of the compound1994Journal of medicinal chemistry, Jul-08, Volume: 37, Issue:14
Anticancer specificity of some ellipticinium salts against human brain tumors in vitro.
AID614179Effect on membrane integrity in Staphylococcus aureus SH1000 at four times MIC after 10 mins by BacLight assay2011Bioorganic & medicinal chemistry, Sep-01, Volume: 19, Issue:17
Ellipticines and 9-acridinylamines as inhibitors of D-alanine:D-alanine ligase.
AID117791The effect on NADH oxidation in the presence of MPO-H2O2 at pH 7.41981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID117506The effect on oxygen uptake in the presence of MPO-H2O2 at pH 8.31981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID614177Antimicrobial activity against Staphylococcus aureus SH1000 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, Sep-01, Volume: 19, Issue:17
Ellipticines and 9-acridinylamines as inhibitors of D-alanine:D-alanine ligase.
AID131305Effect on ip implanted syngeneic B16 melanoma by ip administration for 5 days measured as increase in mean life span; NT=Not tested1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Synthesis and antitumor activity of quaternary ellipticine glycosides, a series of novel and highly active antitumor agents.
AID116287Increase in life span over controls (10e5 cells) in mice after intraperitoneal treatment of the compound.1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID117799The effect on NADH oxidation in the presence of MPO-H2O2 without the compound at pH 6.01981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID78721Cytotoxicity against H 358 human lung cancer cell line1992Journal of medicinal chemistry, Dec-25, Volume: 35, Issue:26
N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
AID614175Antimicrobial activity against Escherichia coli 1411 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, Sep-01, Volume: 19, Issue:17
Ellipticines and 9-acridinylamines as inhibitors of D-alanine:D-alanine ligase.
AID117504The effect on oxygen uptake in the presence of MPO-H2O2 at pH 6.01981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID117795The effect on NADH oxidation in the presence of MPO-H2O2 without compound at pH 7.81981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID97841Lethal concentration required to reduce cloning efficiency to a factor of 0.37 after 24 hour exposure1985Journal of medicinal chemistry, Jun, Volume: 28, Issue:6
Ellipticine derivatives with an affinity to the estrogen receptor, an approach to develop intercalating drugs with a specific effect on the hormone-dependent breast cancer.
AID254810Inhibitory activity against Platelet-derived growth factor receptor alpha2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Molecular modeling of wild-type and D816V c-Kit inhibition based on ATP-competitive binding of ellipticine derivatives to tyrosine kinases.
AID117798The effect on NADH oxidation in the presence of MPO-H2O2.1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID1152802Antiplasmodial activity against Plasmodium falciparum2014Bioorganic & medicinal chemistry letters, Jun-15, Volume: 24, Issue:12
Antiplasmodial activity of synthetic ellipticine derivatives and an isolated analog.
AID117796The effect on NADH oxidation in the presence of MPO-H2O2 without the compound1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID1339151Cytotoxicity against human HeLaS3 cells assessed as reduction in cell viability after 72 hrs by MTT assay2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Determination of binding modes and binding constants for the complexes of 6H-pyrido[4,3-b]carbazole derivatives with DNA.
AID130969Antitumor activity against iv implanted P388 leukemia in mouse after ip administration of 30 mg/kg for 5 days expressed as increase in mean life span1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
Synthesis and antitumor activity of quaternary ellipticine glycosides, a series of novel and highly active antitumor agents.
AID117508The effect on oxygen uptake in the presence of MPO-H2O2 at pH 7.41981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID26756DNA binding dissociation constant as KD1984Journal of medicinal chemistry, Apr, Volume: 27, Issue:4
Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics.
AID78723Cytotoxicity against H 460 human lung cancer cell line1992Journal of medicinal chemistry, Dec-25, Volume: 35, Issue:26
N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
AID255004Inhibitory concentration against c-Kit wild type expressed in recombinant baculovirus2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Molecular modeling of wild-type and D816V c-Kit inhibition based on ATP-competitive binding of ellipticine derivatives to tyrosine kinases.
AID117510The effect on oxygen uptake in the presence of MPO-H2O2 without the compound at pH 6.81981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
AID255976Inhibitory concentration against IL-3 independent Ba/F3 Kit D816V cell line2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Molecular modeling of wild-type and D816V c-Kit inhibition based on ATP-competitive binding of ellipticine derivatives to tyrosine kinases.
AID96665Growth inhibitory activity against L1210 lymphocytic leukemia cells.1983Journal of medicinal chemistry, Oct, Volume: 26, Issue:10
Autoxidation of the antitumor drug 9-hydroxyellipticine and its derivatives.
AID117790The effect on NADH oxidation in the presence of MPO-H2O2 at pH 6.81981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (72)

TimeframeStudies, This Drug (%)All Drugs %
pre-199046 (63.89)18.7374
1990's15 (20.83)18.2507
2000's7 (9.72)29.6817
2010's4 (5.56)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.84 (24.57)
Research Supply Index4.34 (2.92)
Research Growth Index4.18 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (2.63%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other74 (97.37%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]